Vesna Sossi Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2023	Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
6/2020	The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score.
10/2019	The Use of Random Forests to Classify Amyloid Brain PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vesna Sossi Research Topics

Disease

53	Parkinson Disease (Parkinson's Disease) 05/2024 - 02/2002
9	Cognitive Dysfunction 05/2024 - 10/2015
9	Parkinsonian Disorders (Parkinsonism) 10/2017 - 12/2005
6	Dyskinesias (Dyskinesia) 01/2023 - 12/2004
5	Disease Progression 04/2024 - 08/2004
4	Bipolar Disorder (Manic Depressive Psychosis) 12/2022 - 05/2002
4	Mania (Manias) 12/2022 - 05/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2012
2	Neuroinflammatory Diseases 05/2024 - 01/2019
2	Atrophy 04/2024 - 01/2023
2	Mixed Dementias 04/2024 - 10/2015
2	Dementia (Dementias) 01/2023 - 10/2013
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 10/2013
2	Transient Ischemic Attack 06/2020 - 10/2019
2	Leukoencephalopathies 06/2020 - 10/2019
2	Lacunar Stroke 06/2020 - 10/2019
2	Body Weight (Weight, Body) 01/2020 - 05/2012
2	Neoplasms (Cancer) 03/2018 - 01/2017
1	Cerebral Small Vessel Diseases 04/2024
1	Multiple Sclerosis 12/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Intellectual Disability (Idiocy) 10/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Substance-Related Disorders (Drug Abuse) 10/2012
1	Secondary Parkinson Disease (Secondary Parkinsonism) 04/2012
1	Treatment-Resistant Depressive Disorder 06/2010
1	Huntington Disease (Huntington's Disease) 08/2005

Drug/Important Bio-Agent (IBA)

30	Dopamine (Intropin)FDA LinkGeneric 12/2022 - 02/2002
14	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 05/2002
10	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2022 - 11/2007
6	Amyloid (Amyloid Fibrils)IBA 04/2024 - 10/2015
6	RacloprideIBA 01/2021 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2011
5	Leucine (L-Leucine)FDA Link 04/2024 - 12/2005
5	Phosphotransferases (Kinase)IBA 04/2024 - 12/2005
5	Oxidopamine (6 Hydroxydopamine)IBA 05/2012 - 09/2006
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2015
3	SynucleinsIBA 05/2024 - 04/2012
3	Amyloid beta-PeptidesIBA 04/2024 - 01/2017
3	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2021 - 11/2007
3	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021 - 07/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2013
3	Dihydroxyphenylalanine (Dopa)IBA 01/2019 - 05/2002
3	fluorodopa F 18IBA 01/2017 - 02/2002
2	alpha-SynucleinIBA 01/2022 - 01/2017
2	dihydrotetrabenazineIBA 01/2021 - 01/2020
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 01/2017
2	benzonitrileIBA 01/2021 - 01/2018
2	florbetapirIBA 06/2020 - 10/2019
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2018
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 10/2012
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 06/2010
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2010
2	setoperoneIBA 06/2010 - 01/2010
2	Antipsychotic Agents (Antipsychotics)IBA 10/2002 - 05/2002
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2002 - 05/2002
1	LigandsIBA 05/2024
1	Glucosylceramidase (Glucocerebrosidase)IBA 09/2023
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 08/2022
1	Haloperidol (Haldol)FDA LinkGeneric 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2018
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2018
1	O-methyl reboxetineIBA 01/2018
1	AcetylcholinesteraseIBA 01/2018
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2018
1	dextran-2-hydroxy-3-mercaptopropyl ether (C 79)IBA 10/2017
1	AcidsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	5-fluoroaminosuberic acidIBA 01/2017
1	ProgranulinsIBA 10/2013
1	Phospholipases A2 (Phospholipase A2)IBA 11/2012
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2012
1	5-HT2 Serotonin ReceptorsIBA 01/2010
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 12/2004

Therapy/Procedure

7	Therapeutics 01/2020 - 06/2010
6	Denervation 05/2024 - 04/2006
2	Transplantation 08/2005 - 09/2003
1	Radiotherapy 03/2018
1	Deep Brain Stimulation 01/2017
1	Oral Administration 12/2004
1	Aftercare (After-Treatment) 05/2002